Blau Farmacêutica S.A. (BVMF:BLAU3)
12.70
0.00 (0.00%)
Oct 24, 2025, 5:06 PM GMT-3
Blau Farmacêutica Revenue
Blau Farmacêutica had revenue of 464.83M BRL in the quarter ending June 30, 2025, a decrease of -0.06%. This brings the company's revenue in the last twelve months to 1.77B, up 12.22% year-over-year. In the year 2024, Blau Farmacêutica had annual revenue of 1.75B with 27.81% growth.
Revenue (ttm)
1.77B
Revenue Growth
+12.22%
P/S Ratio
1.28
Revenue / Employee
930.22K
Employees
1,900
Market Cap
2.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.75B | 381.74M | 27.81% |
| Dec 31, 2023 | 1.37B | -34.28M | -2.44% |
| Dec 31, 2022 | 1.41B | 40.50M | 2.96% |
| Dec 31, 2021 | 1.37B | 184.60M | 15.62% |
| Dec 31, 2020 | 1.18B | 204.30M | 20.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 52.81B |
| Raia Drogasil | 40.96B |
| Diagnósticos da América | 13.93B |
| Empreendimentos Pague Menos | 13.68B |
| Fleury | 7.84B |
| Hypera | 6.66B |
| Oncoclínicas do Brasil Serviços Médicos | 6.16B |
| Dimed S.A. Distribuidora de Medicamentos | 5.16B |